Table 2. Multivariate analyses for PFS and OS in the patients with ovarian CCCs.
| Variables | PFS | OS | |||||
|---|---|---|---|---|---|---|---|
| HR | 95% CI | p-value | HR | 95% CI | p-value | ||
| Age (yr) | >51 vs. ≤50 | 1.11 | 0.61–2.09 | 0.730 | 0.85 | 0.44–1.65 | 0.620 |
| FIGO stage | III/IV vs. I/II | 4.58 | 2.44–8.77 | <0.010 | 3.84 | 1.82–8.42 | <0.010 |
| Residual tumor at primary surgery | Suboptimal vs. optimal | 3.51 | 1.67–7.11 | <0.010 | 5.02 | 2.28–10.80 | <0.010 |
| LC3A expression | High expression vs. low expression | 2.64 | 1.17–7.12 | 0.020 | 4.45 | 1.53–19.00 | <0.010 |
CCC, clear cell carcinoma; CI, confidence interval; FIGO, the International Federation of Gynecology and Obstetrics; HR, hazard ratio; LC3A, light chain 3A; OS, overall survival; PFS, progression-free survival.